Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
An important open letter from drug manufacturers highlighted a serious safety issue
The classification performance of the method was evaluated using leave-one-out cross validation (LOOCV) on the RF model
A recent clinical trial study that evaluated alterations in CKD patients with diabetes and/or hypertension presenting with stages 2, 3, and 4 of the disease treated with either FMT or placebo capsules for 6 months showed that the patients had similar responses to FMT, regardless of their CKD stage
Composicin: Por 1 cpsula: L-Carnitina
US$ 28.49
US$ 23.56
:format(webp))
US$ 24.72
US$ 28.06
